TrialBMC cancer2022

A randomized controlled phase III study comparing hadrontherapy with carbon ions versus conventional radiotherapy - including photon and proton therapy - for the treatment of radioresistant tumors: the ETOILE trial.

Jacques Balosso et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.